跳至主要内容
临床试验/CTRI/2021/01/030371
CTRI/2021/01/030371招募中未知

Cytomegalovirus reactivation in critically ill immunocompetent patients with septic shock

Sanjay Gandhi Post Graduate Institute of Medical Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • All adult ICU patients (age >= 18 years) who had septic shock will be considering for inclusion in this study.

排除标准

  • 1.Consent not given.
  • 2.Expected survival < 72 hours.
  • 3.Use of antiviral agent cidofovir, foscarnet, ganciclovir, valgancyclovir [HSV treatment doses of acyclovir, valacyclovir, or famciclovir permitted]) within the last 7 days.
  • 4.Known or suspected underlying immune deficiency [history of solid organ or stem cell transplantation, infection with the human immunodeficiency virus, hematological malignancy, use of immunosuppressive medication (more than 0.1 mg prednisone per kilo for more than 3 months, more than 75 mg prednisone per day for more than 1 week, or equivalent), chemotherapy/radiotherapy in the year before ICU admission, and any known humoral or cellular immune deficiency].
  • 5.Pregnancy.

研究者

相似试验